IHC further confirmed that P300-knockdown decreased phospho-Elk1 and downregulated expression of aPKC-ι downstream target phospho-Erk1/2 in HCC tumors (Fig. 5e). The gene discussed is ELK1; the disease is hepatocellular carcinoma.